Microbial Biotechnology is a specialized branch of biotechnology that harnesses the power of microorganisms for various applications. It involves the genetic manipulation, cultivation, and utilization of microorganisms like bacteria, fungi, and viruses to develop products and processes beneficial to industries and society. Microbes play a pivotal role in producing biofuels, pharmaceuticals, and industrial enzymes, contributing to sustainable and eco-friendly solutions. Genetic engineering techniques enable the modification of microbial strains to enhance their capabilities, such as increased productivity or the ability to synthesize valuable compounds.
In the field of agriculture, microbial biotechnology is employed for developing biopesticides, biofertilizers, and promoting plant growth. Microbial processes are crucial in waste treatment and environmental management, aiding in the degradation of pollutants and the remediation of contaminated sites. The study of microbial communities, known as microbiomics, provides insights into various ecosystems and their functions. Continuous advancements in sequencing technologies and synthetic biology further expand the possibilities in microbial biotechnology, paving the way for novel applications and discoveries. The field also addresses ethical considerations, biosafety, and regulatory aspects associated with the use of genetically modified microorganisms.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico